8 Results for "

CES1 Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "CES1 Inhibitors" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-124700
CAS No.: 1966129-74-7
LYPLAL1-IN-1 (compound 11) is a selective, covalent, and irreversible inhibitor of the lysophospholipase-like enzyme LYPLAL1 (IC50 = 6 nM). LYPLAL1-IN-1 shows selectivity against other serine hydrolases such as carboxylesterase CES1 (IC50 > 50 μM for CES1). LYPLAL1-IN-1 inhibits the depalmitoylation function of LYPLAL1, blocking its depalmitoylation modification of cyclic GMP-AMP synthase (cGAS), thereby promoting cGAS dimerization and activation, and initiating the cGAS-STING pathway-mediated innate immune response. LYPLAL1-IN-1 can enhance DNA-induced type I interferon production, upregulate PD-L1 expression in tumor cells, and promote the accumulation of tumor-infiltrating CD8 + T cells, with the core function of strengthening the anti-tumor immune response. LYPLAL1-IN-1 is primarily used in tumor immunology research, especially in combination with PD-1/PD-L1 inhibitors .
loading...
    loading...
Cat. No.: HY-110390
CAS No.: 263890-70-6
Purity:  99.61%
GR148672X is an inhibitor of carboxylesterase 1 (CES1) and hepatic microsomal triglyceride hydrolase (TGH). GR148672X blocks the catalytic activity of CES1, impairs the functions of triglyceride and cholesteryl ester lipase, reduces triglyceride mobilization and secretion, and decreases apolipoprotein B-100 secretion in primary rat hepatocytes. Under low-glucose conditions, GR148672X inhibits the survival of colorectal cancer cells by reducing free fatty acid availability, inducing toxic triglyceride accumulation, ROS production, mitochondrial damage, ferroptosis and apoptosis. GR148672X can be used in studies related to colorectal cancer and atherosclerosis .
loading...
    loading...
Cat. No.: HY-110148
CAS No.: 947669-86-5
Purity:  99.72%
Research Areas:  

Metabolic Disease

WWL113 is a selective and orally active Ces3 and Ces1f inhibitor, with IC50 values of 120 nM and 100 nM for Ces3 and Ces1f, respectively. WWL113 appears to show excellent selectivity for the 60-kDa serine hydrolase (or hydrolases) .
loading...
    loading...
Cat. No.: HY-147331
CAS No.: 208720-71-2
Research Areas:  

Neurological Disease

Oseltamivir acid methyl ester is a precursor form of the neuraminidase inhibitor and antiviral oseltamivir acid. Oseltamivir acid methyl ester is converted to oseltamivir acid by carboxylesterase 1 (CES1) .
loading...
    loading...
Cat. No.: HY-147331A
CAS No.: 208720-78-9
Research Areas:  

Neurological Disease

Oseltamivir acid methyl ester hydrochloride is a precursor form of the neuraminidase inhibitor and antiviral oseltamivir acid. Oseltamivir acid methyl ester hydrochloride is converted to oseltamivir acid by carboxylesterase 1 (CES1) .
loading...
    loading...
Cat. No.: HY-147763
CAS No.: 2087916-31-0
Target:  

HCV

Research Areas:  

Infection

HCV-IN-39 (Compound 18a) is a potent hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.644, 0.952 and 0.154 μM against GT1a, GT1b and GT1b CES1 replicons .
loading...
    loading...
Cat. No.: HY-147764
CAS No.: 2087916-66-1
Target:  

HCV

Research Areas:  

Infection

HCV-IN-40 (Compound 18c) is a potent, orally active hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.259, 0.434 and 0.069 μM against GT1a, GT1b and GT1b CES1 replicons .
loading...
    loading...
Cat. No.: HY-110148R
CAS No.: 947669-86-5
WWL113 (Standard) is the analytical standard of WWL113 (HY-110148). This product is intended for research and analytical applications. WWL113 is a selective and orally active Ces3 and Ces1f inhibitor, with IC50 values of 120 nM and 100 nM for Ces3 and Ces1f, respectively. WWL113 appears to show excellent selectivity for the 60-Kda serine hydrolase (or hydrolases) .
loading...
    loading...